Back
ESC Premium Access

Newly developed atrial fibrillation is an unfavorable sign of anthracycline-induced cardiomyopathy

Session: Cardio-oncology
Topic: Cardiotoxicity of drugs
Speaker: Doctor M. Amioka (Hiroshima, JP)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Michitaka Amioka

Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima (Japan)
0 follower

6 more presentations in this session

Myocardial copper and iron content in failing human heart: the implications for mitochondrial function

Speaker: Doctor V. Melenovsky (Prague, CZ)

Access
Abstract
Slides
Like
Thumbnail

Prevalence and functional significance of cardiac autonomic dysfunction among women with breast cancer

Speaker: Doctor J. Groarke (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Global and regional patterns of longitudinal deformation imaging in the monitoring of chemotherapy-induced cardiotoxicity

Speaker: Doctor G. Portugal (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

4D deformation, arterial stiffness, and cardiac biomarkers for the early detection of chemotherapy-induced cardiotoxicity in patients with nonHodgkin lymphoma

Speaker: Doctor D. Mihalcea (Bucharest, RO)

Access
Abstract
Slides
Like
Thumbnail

Left ventricular end-diastolic volume as an early indicator of Trastuzumab-related cardiotoxicity in patients with HER2 positive breast cancer: results from a single-center retrospective study

Speaker: Doctor F. Torelli (Verona, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardio-oncology

Speakers: Doctor M. Amioka, Doctor V. Melenovsky, Doctor J. Groarke, Doctor G. Portugal, Doctor D. Mihalcea...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources